share_log

南京医药(600713.SH)发布前三季度业绩,净利润4.42亿元,同比增长0.36%

Nanjing Pharmaceutical (600713.SH) released its performance for the first three quarters, with net income of 0.442 billion yuan, a 0.36% year-on-year increase.

Zhitong Finance ·  Oct 30, 2024 16:02

Nanjing Pharmaceutical (600713.SH) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 40...

Zhithong Finance APP News, Nanjing Pharmaceutical (600713.SH) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 40.938 billion yuan, a year-on-year increase of 0.97%; net income attributable to shareholders of the listed company was 0.442 billion yuan, a year-on-year increase of 0.36%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.436 billion yuan, a year-on-year increase of 0.46%; basic earnings per share was 0.34 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment